mobile background

We provide 

the Essential Value


We add value of your understanding of regulatory guidance on


Impurity

Extractables and Leachables

CCIT (Container closure Integrity testing)


Also, Saint-Gobain with Tubing and Bag as Single use system

SWISS BASEL, E&L SCHOOL Welcome KOREA CUSTOMER

🌐 Quality by Design Inc. - Your Trusted Partner in E&L Studies 🌐

At Quality by Design Inc., we pride ourselves on being at the forefront of the Extractables and Leachables (E&L) study landscape. Our comprehensive services cover:


🔍 Consultation on the current E&L study approach 

🔬 Critical assessment and evaluation 

📜 Extractables & Leachables study and profiling 

🧪 Identification & Toxicological evaluations 

🛡️ Risk and Safety assessments 

✅ Regulatory Registration support


Key Areas of Expertise:

  • Container closure systems like glass vials, stoppers, and related products.
  • Single-use systems and process contact materials.
  • All types of Medical Devices.

"We proudly showcase our global regulatory expertise, with a track record of obtaining product approvals across:

  • FDA, EMA, CHINA, KOREA, JAPAN, BRASIL, Türkiye(Turkey) and more.

Have an inquiry or need expert advice? 📩 Reach out to us at qbd@qbd.co.kr

For a more in-depth look at what we offer, visit our official website at www.qbd.co.kr

Let's navigate the complexities of E&L together! We look forward to partnering with you. 💼🌟


E&L and Pharmaceutical Regulatory Compliance AI 

의약품 인허가 관련 질문하시고 간단한 답변 받으실 수 있습니다.


E&L Guidance LawPDMA Update (Modernization of USP Packaging Standards for Glass and Elastomeric Components )

관리자
2019-07-22
조회수 3172


Modernization of USP Packaging Standards for Glass and Elastomeric Components 


The modernization of USP (United States Pharmacopeia) packaging standards has been ongoing since 2015 1), 2). On June 19-20, 2017, USP conducted a workshop to discuss the modernization of its glass and elastomeric standards 3). During this workshop, USP Expert Committee members gave an overview, background and rationale for the proposed revision to the glass and elastomeric standard. There were also presentations on current U.S. Date Title Location September 10-12 RAPS (Regulatory Affairs Professional Society) Annual Conference Washington, D.C. September 11-12 PIC/S (Pharmaceutical Inspection Cooperation Scheme) Committee Taipei September 17-18 GCRSR/GSRS Brasilia September 19-21 12th IMDRF Management Committee Meeting Ottawa October 9-10 CoRE Advisory Board Meeting Singapore October 23-26 12th International Summit of Heads of Medicines Regulatory Agencies / International Coalition of Medicines Regulatory Authorities (ICMRA) Kyoto PMDA Updates August, 2017 Page 5 regulations related to pharmaceutical packaging and on analytical methods for determining packaging containers quality. Dr. Yukio Hiyama, a Japanese Pharmacopoeia (JP) Expert Committee member who works at the National Institute of Health Sciences (NIHS) attended the workshop, and gave a presentation on the packaging requirements in JP 17th Edition. During his presentation, he also outlined the pharmaceutical packaging chapter revisions in the first supplement to JP 17th Edition, including a new general information chapter for glass containers. 


By attending this workshop, I was able to learn: ①the importance of the packaging system impacting on drug product quality and patient safety; ②majority of the particles that you find in a finished drug product comes from the packaging system and its assembly; ③ in the select of a packaging material/component one has to have a basic understanding of the component characteristics and the intended use of the component (e.g. oral product vs. injection) and: ④ the necessity to set the appropriate control specifications, based on information about the component and its manufacturing process. 


The management of pharmaceutical packaging is important in order to assure product/packaging compatibility, quality and safety. Therefore, I will keep watching trends of technologies and regulations related to pharmaceutical packaging. 


1) Comment Period Extended for Packaging General Chapters Appearing in Pharmacopeial Forum 43(3) http://www.uspnf.com/notices/comment-period-extended-packaging-general-chapters-appearingpharmacopeial-forum-43-3 

2) General Chapters: <659> Packaging and Storage Requirements, <661> Plastic Packaging Systems and Their Materials of Construction, <661.1>Plastic Materials of Construction, <661.2> Plastic Packaging Systems for Pharmaceutical Use http://www.uspnf.com/notices/general-chapters-plastic 

3) USP Workshop on Modernization of USP Packaging Standards for Glass and Elastomeric Components http://www.usp.org/meetings-courses/workshops/modernization-usp-packaging-standards-glass-andelastomeric-components 


Dr. Yujiro Kameyama 

PMDA’s Liaison Officer stationed at USP in the U.S.A 

155 0